Sant’Anna-Silva, A.C.B.; Perez-Valencia, J.A.; Sciacovelli, M.; Lalou, C.; Sarlak, S.; Tronci, L.; Nikitopoulou, E.; Meszaros, A.T.; Frezza, C.; Rossignol, R.;
et al. Succinate Anaplerosis Has an Onco-Driving Potential in Prostate Cancer Cells. Cancers 2021, 13, 1727.
https://doi.org/10.3390/cancers13071727
AMA Style
Sant’Anna-Silva ACB, Perez-Valencia JA, Sciacovelli M, Lalou C, Sarlak S, Tronci L, Nikitopoulou E, Meszaros AT, Frezza C, Rossignol R,
et al. Succinate Anaplerosis Has an Onco-Driving Potential in Prostate Cancer Cells. Cancers. 2021; 13(7):1727.
https://doi.org/10.3390/cancers13071727
Chicago/Turabian Style
Sant’Anna-Silva, Ana Carolina B., Juan A. Perez-Valencia, Marco Sciacovelli, Claude Lalou, Saharnaz Sarlak, Laura Tronci, Efterpi Nikitopoulou, Andras T. Meszaros, Christian Frezza, Rodrigue Rossignol,
and et al. 2021. "Succinate Anaplerosis Has an Onco-Driving Potential in Prostate Cancer Cells" Cancers 13, no. 7: 1727.
https://doi.org/10.3390/cancers13071727
APA Style
Sant’Anna-Silva, A. C. B., Perez-Valencia, J. A., Sciacovelli, M., Lalou, C., Sarlak, S., Tronci, L., Nikitopoulou, E., Meszaros, A. T., Frezza, C., Rossignol, R., Gnaiger, E., & Klocker, H.
(2021). Succinate Anaplerosis Has an Onco-Driving Potential in Prostate Cancer Cells. Cancers, 13(7), 1727.
https://doi.org/10.3390/cancers13071727